Replies to post #4825 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Would GTCB be due any royalties [on Rhucin sales] due to patent issues?

If GTC is due a royalty on Rhucin sales, I doubt that it’s material. I’ll post again if I find out otherwise. Regards, Dew